Hepatocyte growth factor production by neutrophils infiltrating bronchioloalveolar subtype pulmonary adenocarcinoma: Role in tumor progression and death

Cancer Research

Volumn 63, Issue 6, 2003, Pages 1405-1412

  Wislez, Marie ^a,b   Rabbe, Nathalie ^b   Marchal, Joëlle ^c   Milleron, Bernard ^b   Crestani, Bruno ^c   Mayaud, Charles ^b   Antoine, Martine ^a,b   Soler, Paul ^c   Cadranel, Jacques ^a,b  

^a HÔPITAL TENON   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR RECEPTOR; MESSENGER RNA; SCATTER FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CANCER RESEARCH; CONCENTRATION RESPONSE; CYTOKINE RELEASE; FEMALE; HUMAN; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; LUNG ALVEOLUS CELL; LUNG ALVEOLUS CELL CARCINOMA; LUNG TUMOR; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NEUTROPHIL CHEMOTAXIS; ONCOGENE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; STATISTICAL ANALYSIS; TUMOR CELL; TUMOR GROWTH;

ADENOCARCINOMA, BRONCHIOLO-ALVEOLAR; ADULT; AGED; AGED, 80 AND OVER; BRONCHOALVEOLAR LAVAGE FLUID; DISEASE PROGRESSION; FEMALE; HEPATOCYTE GROWTH FACTOR; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEUTROPHILS; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-MET;

EID: 0037444169     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Shimosato, Y., Noguchi, M., and Matsuno, Y. Adenocarcinoma of the lung: its development and malignant progression. Lung Cancer, 9: 99-108, 1993.
2. Travis, W. D., Lubin, J., Ries, L., and Devesa, S. United States lung carcinoma incidence trends: declining for most histologic types among males, increasing among females. Cancer (Phila.), 77: 2464-2470, 1996.
3. Noguchi, M., Morikawa, A., Kawasaki, M., Matsuno, Y., Yamada, T., Hirohashi, S., Kondo, H., and Shimosato, Y. Small adenocarcinoma of the lung. Histologic characteristics and prognosis. Cancer (Phila.), 75: 2844-2852, 1995.
4. Mountain, C. F. Revisions in the International System for Staging Lung Cancer. Chest, 111: 1710-1717, 1997.
5. Roggli, V. L., Vollmer, R. T., Greenberg, S. D., McGavran, M. H., Spjut, H. J., and Yesner, R. Lung cancer heterogeneity: a blinded and randomized study of 100 consecutive cases. Hum. Pathol., 16: 569-579, 1985.
6. Mori, M., Rao, S. K., Popper, H. H., Cagle, P, T., and Fraire, A. E. Atypical adenomatous hyperplasia of the lung: a probable forerunner in the development of adenocarcinoma of the lung. Mod. Pathol., 14: 72-84, 2001.
7. Wislez, M., Fleury-Feith, J., Rabbe, N., Moreau, J., Cesari, D., Milleron, B., Mayaud, C., Antoine, M., Soler, P., and Cadranel, J. Tumor-derived granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor prolong the survival of neutrophils infiltrating bronchoalveolar subtype pulmonary adenocarcinoma. Am. J. Pathol., 159: 1423-1433, 2001.
8. Bellocq, A., Antoine, M., Flahault, A., Philippe, C., Crestani, B., Bemaudin, J. F., Mayaud, C., Milleron, B., Baud, L., and Cadranel, J. Neutrophil alveolitis in bronchioloalveolar carcinoma: induction by tumor-derived interleukin-8 and relation to clinical outcome. Am. J. Pathol., 152: 83-92, 1998.
9. Bottaro, D. P., Rubin, J. S., Faletto, D. L., Chan, A. M., Kmiecik, T. E., Vande Woude, G. F., and Aaronson, S. A. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science (Wash. DC), 251: 802-804, 1991.
10. Grant, D. S., Kleinman, H. K., Goldberg, I. D., Bhargava, M. M., Nickoloff, B. J., Kinsella, J. L., Polverini, P., and Rosen, E. M. Scatter factor induces blood vessel formation in vivo. Proc. Natl. Acad. Sci. USA, 90: 1937-1941, 1993.
11. Weidner, K. M., Sachs, M., and Birchmeier, W. The Met receptor tyrosine kinase transduces motility, proliferation, and morphogenic signals of scatter factor/hepatocyte growth factor in epithelial cells. J. Cell Biol., 121: 145-154, 1993.
12. Dohi, M., Hasegawa, T., Yamamoto, K., and Marshall, B. C. Hepatocyte growth factor attenuates collagen accumulation in a murine model of pulmonary fibrosis. Am. J. Respir. Crit. Care Med., 162: 2302-2307, 2000.
13. Adamson, I. Y., and Bakowska, J, Relationship of keratinocyte growth factor and hepatocyte growth factor levels in rat lung lavage fluid to epithelial cell regeneration after bleomycin. Am. J. Pathol., 155: 949-954, 1999.
14. Siegfried, J. M., Weissfeld, L. A., Singh-Kaw, P., Weyant, R. J., Testa, J. R., and Landreneau, R. J. Association of immunoreactive hepatocyte growth factor with poor survival in resectable non-small cell lung cancer. Cancer Res., 57:433-439, 1997.
15. Ramirez, R., Hsu, D., Patel, A., Fenton, C., Dinauer, C., Tuttle, R. M., and Francis, G. L. Over-expression of hepatocyte growth factor/scatter factor (HGF/SF) and the HGF/SF receptor (cMET) are associated with a high risk of metastasis and recurrence for children and young adults with papillary thyroid carcinoma. Clin. Endocrinol., 53: 635-644, 2000.
16. Yamashita, J., Ogawa, M., Yamashita, S., Nomura, K., Kuramoto, M., Saishoji, T., and Shin, S. Immunoreactive hepatocyte growth factor is a strong and independent predictor of recurrence and survival in human breast cancer. Cancer Res., 54: 1630-1633, 1994.
17. Niki, M., Isozaki, H., Toyoda, M., Ishibashi, T., Fujii, K., Nomura, E., Mabuchi, H., Nakamura, M., Nishiguchi, K., and Tanigawa, N. Serum human hepatocyte growth factor (hHGF) is elevated in patients with metastatic gastric carcinoma. Hepatogastroenterology, 46: 568-573, 1999.
18. Grenier, A., Chollet-Martin, S., Crestani, B., Delarche, C., El Benna, J., Boutten, A., Andrieu, V., Durand, G., Gougerot-Pocidalo, M. A., Aubier, M., and Dehoux, M. Presence of a mobilizable intracellular pool of hepatocyte growth factor in human polymorphonuclear neutrophils. Blood. 99: 2997-3004, 2002.
19. Barsky, S. H., Cameron, R., Osann, K. E., Tomita, D., and Holmes, E. C. Rising incidence of bronchioloalveolar lung carcinoma and its unique clinicopathologic features. Cancer (Phila.), 73: 1163-1170, 1994.
20. Nakamura, T., Nishizawa, T., Hagiya, M., Seki, T., Shimonishi, M., Sugimura, A., Tashiro, K., and Shimizu, S. Molecular cloning and expression of human hepatocyte growth factor. Nature (Lond.). 342: 440-44, 31989
21. Varani, J., Orr, W., and Ward, P. A. A comparison of the migration patterns of normal and malignant cells in two assay systems. Am. J. Pathol., 90: 159-171, 1978.
22. Lieber, M., Smith, B., Szakal, A., Nelson-Rees, W., and Todaro, G. A continuous tumor-cell line from a human lung carcinoma with properties of type II alveolar epithelial cells. Int. J. Cancer., 17: 62-70, 1976.
23. To, Y., Dohi, M., Matsumoto, K., Tanaka, R., Sato, A., Nakagome, K., Nakamura, T., and Yamamoto, K. A two-way interaction between hepatocyte growth factor and interleukin-6 in tissue invasion of lung cancer cell line. Am. J. Respir. Cell Mol. Biol., 27: 220-226, 2002.
24. Singh-Kaw, P., Zarnegar, R., and Siegfried, J. M. Stimulatory effects of hepatocyte growth factor on normal and neoplastic human bronchial epithelial cells. Am. J. Physiol., 268: L1012-L1020, 1995.
25. Tsao, M. S., Yang, Y., Marcus, A., Liu, N., and Mou, L. Hepatocyte growth factor is predominantly expressed by the carcinoma cells in non-small-cell lung cancer. Hum. Pathol., 32: 57-65, 2001.
26. Yamashita, J., Ogawa, M., Nakano, S., Okabe, K., Abe, M., Iwasaki, A., Kuwahara, M., Yoshinaga, Y., and Shirakusa, T. High levels of hepatocyte growth factor/scatter factor in diffuse-type bronchioloalveolar cell carcinoma. Cancer (Phila.), 83: 2091-2098, 1998.
27. Takanami, I., Tanana, F., Hashizume, T., Kikuchi, K., Yamamoto, Y., Yamamoto, T., and Kodaira, S. Hepatocyte growth factor and c-Met/hepatocyte growth factor receptor in pulmonary adenocarcinomas: an evaluation of their expression as prognostic markers. Oncology, 53: 392-397, 1996.
28. Harvey, P., Warn, A., Newman, P., Perry, L. J., Ball, R. Y., and Warn, R. M. Immunoreactivity for hepatocyte growth factor/scatter factor and its receptor, met, in human lung carcinomas and malignant mesotheliomas. J. Pathol., 180: 389-394, 1996.
29. Jaffre, S., Dehoux, M., Paugam, C., Grenier, A., Chollet-Martin, S., Stern, J. B., Mantz, J., Aubier, M., and Crestani, B. Hepatocyte growth factor is produced by blood and alveolar neutrophils in acute respiratory failure. Am. J. Physiol. Lung Cell. Mol. Physiol., 282: L310-L315, 2002.
30. Sakai, T., Satoh, K., Matsushima, K., Shindo, S., Abe, S., Abe, T., Motomiya, M., Kawamoto, T., Kawabata, Y., Nakamura, T., and Nukiwa, T. Hepatocyte growth factor in bronchoalveolar lavage fluids and cells in patients with inflammatory chest diseases of the lower respiratory tract: detection by RIA and in situ hybridization. Am. J. Respir. Cell Mol. Biol., 16: 388-397, 1997.
31. Morimoto, K., Amano, H., Sonoda, F., Baba, M., Senba, M., Yoshimine, H., Yamamoto, H., Ii, T., Oishi, K., and Nagatake, T. Alveolar macrophages that phagocytose apoptotic neutrophils produce hepatocyte growth factor during bacterial pneumonia in mice. Am. J. Respir. Cell Mol. Biol., 24: 608-615, 2001.
32. Nakamura, T., Matsumoto, K., Kiritoshi, A., and Tano, Y. Induction of hepatocyte growth factor in fibroblasts by tumor-derived factors affects invasive growth of tumor cells: in vitro analysis of tumor-stromal interactions. Cancer Res., 57: 3305-3313, 1997.
33. Chollet-Martin, S., Jourdain, B., Gibert, C., Elbim, C., Chastre, J., and Gougerot-Pocidalo, M. A. Interactions between neutrophils and cytokines in blood and alveolar spaces during ARDS. Am. J. Respir. Crit. Care Med., 154: 594-601, 1996.
34. Trusolino, L., Pugliese, L., and Comoglio, P. M. Interactions between scatter factors and their receptors: hints for therapeutic applications. FASEB J., 12: 1267-1280, 1998.
35. Tokunou, M., Niki, T., Eguchi, K., Iba, S., Tsuda, H., Yamada, T., Matsuno, Y., Kondo, H., Saitoh, Y., Imamura, H., and Hirohashi, S. c-MET expression in myofibroblasts: role in autocrine activation and prognostic significance in lung adenocarcinoma. Am. J. Pathol., 158: 1451-1463, 2001.
36. Jiang, W., Hiscox, S., Matsumoto, K., and Nakamura, T. Hepatocyte growth factor/scatter factor, its molecular, cellular and clinical implications in cancer. Crit. Rev. Oncol. Hematol., 29: 209-248, 1999.
37. Revoltella, R. P., Dal Canto, B., Caracciolo, L., and D'Urso. C. M. L-carnitine and some of its analogs delay the onset of apoptotic cell death initiated in murine C2.8 hepatocytic cells after hepatocyte growth factor deprivation. Biochim. Biophys. Acta., 1224: 333-341, 1994.
38. Matsumoto. K., Kagoshima, M., and Nakamura, T. Hepatocyte growth factor as a potent survival factor for rat pheochromocytoma PC12 cells. Exp. Cell Res., 220: 71-78, 1995.
39. Muraoka, R. S., Dumont, N., Ritter, C. A., Dugger, T. C., Brantley, D. M., Chen, J., Easterly, E., Roebuck, L. R., Ryan, S., Gotwals, P. J., Koteliansky, V., and Arteaga, C. L. Blockade of TGF-β inhibits mammary tumor cell viability, migration, and metastases. J. Clin. Investig., 109: 1551-1559, 2002.
40. Zhang, X., and Yee, D. Insulin-like growth factor binding protein-I (IGFBP-1) inhibits breast cancer cell motility. Cancer Res., 62: 4369-4375, 2002.
41. Zang, X. P., and Pento, J. T. Keratinocyte growth factor-induced motility of breast cancer cells. Clin. Exp. Metastasis, 18: 573-580, 2000.
42. Morotti, A., Mila, S., Accornero, P., Tagliabue, E., and Ponzetto, C. K252a inhibits the oncogenic properties of Met, the HGF receptor. Oncogene, 21: 4885-4893, 2002.
43. Date, K., Matsumoto, K., Kuba, K., Shimura, H., Tanaka, M., and Nakamura, T. Inhibition of tumor growth and invasion by a four-kringle antagonist (HGF/NK4) for hepatocyte growth factor. Oncogene, 17: 3045-3054, 1998.
44. Saga, Y., Mizukami, H., Suzuki, M., Urabe, M., Kume, A., Nakamura, T., Sato, I., and Ozawa, K. Expression of HGF/NK4 in ovarian cancer cells suppresses intraperitoneal dissemination and extends host survival. Gene Ther., 8: 1450-1455, 2001.